Evidence map›Paper›PMID 36839628›Full record

ArticlePharmaceutics2023

Lipid Liquid Crystal Nanoparticles: Promising Photosensitizer Carriers for the Treatment of Infected Cutaneous Wounds.

Muhammed Awad, Zlatko Kopecki, Timothy J Barnes, Anthony Wignall, Paul Joyce, Nicky Thomas, Clive A Prestidge

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Muhammed AwadCentre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide, SA 5000, Australia.ORCID 0000-0002-0402-6406
Zlatko KopeckiFuture Industries Institute, STEM Academic Unit, University of South Australia, Mawson Lakes, SA 5095, Australia.ORCID 0000-0002-8072-4222
Timothy J BarnesCentre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide, SA 5000, Australia.ORCID 0000-0001-7367-3925
Anthony WignallCentre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide, SA 5000, Australia.
Paul JoyceCentre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide, SA 5000, Australia.ORCID 0000-0003-3619-7901
Nicky ThomasCentre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide, SA 5000, Australia.
Clive A PrestidgeCentre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide, SA 5000, Australia.ORCID 0000-0001-5401-7535
University of South Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous chronic wounds impose a silent pandemic that affects the lives of millions worldwide. The delayed healing process is usually complicated by opportunistic bacteria that infect wounds.

Indexed as

antimicrobialchronic woundsliquid crystal nanoparticlesphotodynamic therapy

Identifiers

PMID36839628
PMCPMC9964009
OpenAlexW4316672602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.